What is LOPJLB’s current signal on XRTX?

LOPJLB’s latest quantitative signal on XORTX Therapeutics Inc. (XRTX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is XRTX in?

XORTX Therapeutics Inc. (XRTX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does XORTX Therapeutics Inc. (XRTX) do?

XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to advancing and bringing to market medical treatments targeting a range of conditions, including chronic kidney ailments, diabetes, insulin resistance, metabolic syndrome, diabetic nephropathy, and various infections. Their pipeline includes XRx-008, a late-stage clinical program designed to address autosomal dominant polycystic kid…

Where is XORTX Therapeutics Inc. based / listed?

XORTX Therapeutics Inc. is based in CA, listed on NASDAQ.

XORTX Therapeutics Inc. (XRTX)

COMPARE

Healthcare · Biotechnology · NASDAQ · CA

$1.41-23.78%Close

SELLCRISIS · day 20

[SCORES & PROFILE]

FUND: 9
VALUE: 27
GROWTH: 39
GARP: 0
TYPE: Value / Recovery

Composite of Value · Growth · GARP

ROIC-76.2%

REV YoY-

ROE-127.0%

EPS YoY-

ROA-59.7%

GROSS

NET

[VALUATION]

P/E TTM-0.31

P/E FWD0.49

SECTOR PE20.47

INDUSTRY PE13.95

P/B0.66

P/FCF-

EV/EBITDA0.10

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO3.59

ND/EBITDA-

BETA0.08

XORTX Therapeutics Inc. (XRTX)

Key stats

Prediction markets

FUNDAMENTALS

Company news